LUXTURNA® (voretigene neparvovec-rzyl) - Inherited Retinal …
LUXTURNA (voretigene neparvovec-rzyl) is a prescription gene therapy product used for the treatment of patients with inherited retinal disease due to mutations in both copies of the RPE65 gene, which can only be confirmed through genetic testing. You must also have enough remaining cells in your retina (the thin layer of tissue in the back of ...
What is LUXTURNA? - LUXTURNA® (voretigene neparvovec-rzyl)
LUXTURNA is the first prescription gene therapy product to help improve functional vision in patients with an inherited retinal disease (IRD) due to a mutation in their RPE65 gene. It is a one-time gene therapy that has the potential to restore the …
How does LUXTURNA work? - LUXTURNA® (voretigene …
Gene therapy is a method for treating or preventing genetic disease. One approach to gene therapy is delivering a new or functional gene into a cell, which is how LUXTURNA works. Working to restore the visual cycle. The visual cycle is a process that allows you to see.
Take your first step - LUXTURNA® (voretigene neparvovec-rzyl)
Confirming mutations in both copies of the RPE65 gene is the first step to determine if you may be appropriate for treatment with LUXTURNA ®.
Patient resources - LUXTURNA® (voretigene neparvovec-rzyl)
LUXTURNA (voretigene neparvovec-rzyl) is a prescription gene therapy product used for the treatment of patients with inherited retinal disease due to mutations in both copies of the RPE65 gene, which can only be confirmed through genetic testing. You must also have enough remaining cells in your retina (the thin layer of tissue in the back of ...
Find a specialist - LUXTURNA® (voretigene neparvovec-rzyl)
LUXTURNA (voretigene neparvovec-rzyl) is a prescription gene therapy product used for the treatment of patients with inherited retinal disease due to mutations in both copies of the RPE65 gene, which can only be confirmed through genetic testing. You must also have enough remaining cells in your retina (the thin layer of tissue in the back of ...
Stay up to date - LUXTURNA® (voretigene neparvovec-rzyl)
LUXTURNA (voretigene neparvovec-rzyl) is a prescription gene therapy product used for the treatment of patients with inherited retinal disease due to mutations in both copies of the RPE65 gene, which can only be confirmed through genetic testing.
LUXTURNA (voretigene neparvovec-rzyl) is an adeno-associated virus vector-based gene therapy indicated for the treatment of patients with confirmed biallelic RPE65 mutation-associated retinal dystrophy.
Site Map - LUXTURNA® (voretigene neparvovec-rzyl)
LUXTURNA (voretigene neparvovec-rzyl) is a prescription gene therapy product used for the treatment of patients with inherited retinal disease due to mutations in both copies of the RPE65 gene, which can only be confirmed through genetic testing. You must also have enough remaining cells in your retina (the thin layer of tissue in the back of ...